Arcellx (ACLX) Other financing activities (2021 - 2025)
Arcellx's (ACLX) quarterly Other financing activities came in at -$3.2 million in Q4 2025, up 65.85% year-on-year from -$1.9 million in Q4 2024, and down 516.97% quarter-over-quarter from $772000.0 in Q3 2025.
Arcellx (ACLX) Other financing activities (2021 - 2025) Analysis & Trends
Arcellx's Other financing activities history runs 5 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- On a quarterly basis, Other financing activities rose 65.85% year-over-year to -$3.2 million in Q4 2025; TTM through Sep 2025 was -$6.2 million, a 102.95% decrease from a year earlier, with the FY2024 full-year figure at $1.2 million, up 6.69% from the prior year.
- Other financing activities declined to -$3.2 million in Q4 2025 per ACLX's latest filing, from $772000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $200.0 million in Q4 2023 and bottomed at -$9.6 million in Q2 2022.
- The 5-year median for Other financing activities is $772000.0 (2025), against an average of $12.0 million.
- Biggest YoY gain for Other financing activities was 142757.14% in 2022; the steepest drop was 5569.14% in 2022.
- Year by year, Other financing activities stood at $187000.0 in 2021, then jumped by 4995.72% to $9.5 million in 2022, then jumped by 1998.86% to $200.0 million in 2023, then sank by 104.71% to -$9.4 million in 2024, then jumped by 65.85% to -$3.2 million in 2025.
- Per Business Quant, the three latest ACLX Other financing activities figures stand at -$3.2 million (Q4 2025), $772000.0 (Q3 2025), and $1.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.22 Mn |
| Dec 31, 2025 | -3.22 Mn |
| Sep 30, 2025 | 772,000.00 |
| Sep 30, 2025 | 772,000.00 |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 772,000.00 |
| Mar 31, 2025 | 772,000.00 |
| Dec 31, 2024 | -9.43 Mn |
| Dec 31, 2024 | -9.43 Mn |
| Sep 30, 2024 | 3.70 Mn |
| Sep 30, 2024 | 3.70 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 4.60 Mn |
| Mar 31, 2024 | 4.60 Mn |
| Dec 31, 2023 | 200.00 Mn |
| Dec 31, 2023 | 200.00 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Sep 30, 2023 | 4.05 Mn |